CANDEL THERAPEUTICS INC

$CADL
Smart money positioned

6 of the Top-200 alpha managers hold $CADL as of the latest 13F snapshot.

13F holders
106
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

6 holders · Q1 2026

$CADL is held by 6 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 1.28%, with an average of 0.48% of portfolio. Largest holder: Heights Capital Management, Inc. at 1.28%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 106 · Source: 13F-HR
01
Key Colony Management, LLC
0.80% of portfolio
5,788,650 sh
02
Mink Brook Asset Management LLC
4.89% of portfolio
3,497,948 sh
03
Strategic Investment Solutions, Inc.
2.57% of portfolio
2,896,588 sh
04
Main Street Group, LTD
0.15% of portfolio
1,125,000 sh
05
Evergreen Capital Management LLC
1,060,086 sh
06
Venator Management LLC
0.97% of portfolio
904,051 sh
07
Axa S.a.
818,558 sh
08
State Street
792,218 sh
09
Silver Oak Securities, Incorporated
1.28% of portfolio
775,000 sh
10
Brightline Capital Management, LLC
498,300 sh
See all 106 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $CADL in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $CADL in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 12:21 UTC.